Jaguar Health Analyst Price Targets - Benzinga

Jaguar Health Inc

JAGXNASDAQ

Trade with Public

Trade with Public

$4.53

-0.47-9.4%

Dern. MÀJ: Oct 8, 7:53 PM

$4.61

-0.39-7.72%

Aperçu Actualités Prévisions de résultats ÉvénementsObjectifs de coursDonnées financières Sentiment Actionnariat Comparer Rapport sur les stocks

Jaguar Health Analyst Price Targets - Benzinga

Jaguar Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Jaguar Health (JAGX).

Price Target Range — 1 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$31500Upside to Avg. PT+682604.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →

Date	Firm	Analyst	Action	Rating Change	Price Target
May 19, 2025	First Berlin	Christian Orquera	Initiate	Buy	$60

Analyst Ratings News

PRO
First Berlin Initiates Coverage On Jaguar Health with Buy Rating, Announces Price Target of $60

First Berlin analyst Christian Orquera initiates coverage on Jaguar Health (NASDAQ:JAGX) with a Buy rating and announces Price Target of $60.

Benzinga Newsdesk

UPDATE: Ladenburg Thalmann Says Jaguar Health Price Target Reflects 1-For-3 Reverse Stock Split And Higher Revenue Anticipated Through Commercialization Within Veterinary Market

Bill Haddad

UPDATE: Ladenburg Thalmann Says Jaguar Health Price Target Reflects 1-For-3 Reverse Stock Split And Higher Revenue Anticipated Through Commercialization Within Veterinary Market

Bill Haddad

Ladenburg Thalmann Raises Jaguar Health Price Target To $13

Bill Haddad

Why Jaguar Health Shares Are Trading Higher Today

Jaguar Health (NASDAQ: JAGX) shares are trading higher after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating and a $5 price target.

Bill Haddad

Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2021

Benzinga Insights